Catalyst Wire Dossier Catalyst Wire Dossier

Apolipoprotein C1

apolipoprotein C1
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Apolipoprotein C1, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients [NA]

See pricing